Correlation Between Dyadic International and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Dyadic International and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Conduit Pharmaceuticals.
Diversification Opportunities for Dyadic International and Conduit Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dyadic and Conduit is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Dyadic International i.e., Dyadic International and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dyadic International and Conduit Pharmaceuticals
Given the investment horizon of 90 days Dyadic International is expected to generate 32.74 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, Dyadic International is 9.81 times less risky than Conduit Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Conduit Pharmaceuticals on September 12, 2024 and sell it today you would lose (12.93) from holding Conduit Pharmaceuticals or give up 92.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 35.56% |
Values | Daily Returns |
Dyadic International vs. Conduit Pharmaceuticals
Performance |
Timeline |
Dyadic International |
Conduit Pharmaceuticals |
Dyadic International and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Conduit Pharmaceuticals
The main advantage of trading using opposite Dyadic International and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |